In July this year we reported on the major increase in measles notifications in the United States. We suggested the country should be "shown the red card" and lose its measles free status.
The Pan American Health Organisation (PAHO), a working group within WHO has now announced the decision and the United States joins Canada, the UK and Spain who have all lost their measles free status in the last 12 months.
According to the World Health Organisation (WHO), measles free status is defined as
"the absence of continuous, endemic local transmission of the measles virus in a defined geographic area for 12 months or longer".
Measles notifications have skyrocketed in the United States over the past 2 years. It is hard to believe the change from early 2000.
Measles Cases in the United States
| YEAR | CASES |
|---|---|
| 2000 | 85 |
| 2001 | 116 |
| 2002 | 44 |
| 2024 | 285 |
| 2025 | 2289 |
| 2026 | 5412 |
What about Australia?
I'm sure the health minister would be packing his bag if we had a similar picture here in Australia. We do have some concerns with our childhood immunization rates, but the message seems to be getting out to the community.
Most of our notifications are in travellers rather than transmission within the population. Maintaining a high immunization rate (> 95%) is critical to reducing the risk of local transmission.
The impact of 5,000 measles notifications
Some people might want to trivialize the disease – it's just measles! But for those of us who have lived through major epidemics and experienced the impact at a personal level, we see it as a major failure of public health policy.
Let us consider the 5,000 notifications this year. Using this figure, we can estimate 1,000 hospitalisations, 5 to 15 deaths and perhaps 10 cases of measles encephalitis. It is likely 40% of those with measles encephalitis will have long term neurological damage.
A case of subacute sclerosing encephalitis (SSPE) might not arise from 5,000 notifications but it is highly likely we will see more cases in the future if the measles outbreak continues. I diagnosed several cases of SSPE in the 1980's in the UK. The news was devastating to the family who were only a bit concerned because their primary school child wasn't doing as well at school.
This neurodegenerative disease due to measles would ultimately be fatal.
How can we rationalize the morbidity due to measles when it can be prevented by vaccination.
What this means for Australian travellers
More than 125 cases of measles have been notified to Australia's surveillance to November 18, 2026.
There were NO cases of measles reported for a similar period between January 1, 2021, and 18 July 2021 when our international borders were closed!
Measles is a highly infectious disease. Over 90% of non-immune individuals exposed to the disease will become symptomatic. The global risk of measles has increased over the last 2 years.
All travellers, particularly those born after 1966 should be assessed for their current measles immunisation status. Special attention should be given to the cohort of unvaccinated infants.
Not sure of your measles immunisation status?
Our travel medicine doctors can check your vaccination history and arrange any doses you need before you travel, by telehealth, Australia-wide.
History of Measles Vaccination in Australia
The live attenuated measles vaccine was first registered in Australia in 1968. It was recommended for children aged 12 to 23 months and given as a single dose vaccination with no booster dose advised. This was not unreasonable given that measles was circulating in the population, and the disease might have served as a booster dose. Any illness would have gone unnoticed at the time.
Measles – mumps was recommended for use in 1982 and later in 1989 was replaced by measles-mumps-rubella (MMR).
As more of the population became immune, transmission reduced and in 1992 a second dose of the MMR vaccine was recommended for all children. The rubella vaccination program for females was replaced by a school-based MMR program for all children aged between 10 and 14 years. All these individuals would have had birth dates in the late 1970's.
It is also important to be aware that prior to the start of measles immunisations, most women would have experienced a bout of the wild disease and hence have a higher antibody response. Children born to these women would have had higher antibody protection during the first year of life, perhaps lasting for up to 8 months. This is not the case for children born to women who have vaccine induced immunity. It is highly unlikely that this immunity affords much protection beyond 3-4 months. This has been investigated in recent years.
This concern might not be an issue if measles transmission was controlled. Australia was declared free of measles in 2014, but a fall in vaccination rates has allowed it back into the country albeit in a limited amount so far. We still have good herd immunity, but this cannot be said for many overseas destinations. This is the reason why travel medicine providers for many years have been giving an early dose of the vaccine to children aged between 6 and 12 months traveling to high-risk destinations. Are we now at a point of saying any destination? I believe this is the case.
It is important that all overseas travellers be aware of the historical aspects of measles vaccination in Australia and why we have been targeting those who have birthdates between 1966 and 1980 and those who have never been vaccinated (children 6 - 12 months).
As public health providers we often fail to sell the message well.
Current Recommendations
- Infants 6–11 months of age should be considered for at least one dose of measles containing vaccine. Most mothers of today have vaccine immunity rather than natural immunity. This provides protection for a shorter period.
- Preschool children ≥12 months of age should have two doses of MMR vaccine separated by at least 28 days.
- School-age children should have two doses of MMR.
- Adults born in or after 1966 should have two doses of measles-containing vaccine.
- If administered at ≥12 months of age, one dose of measles-containing vaccine or MMR is 95% effective in preventing measles disease and two doses are 99% effective. One dose of measles-containing vaccine or MMR is approximately 85% effective if administered at 9 months of age.


